We previously showed in animal models that abrogation of TMPRSS4 using short hairpin RNA (shRNA) strategies impedes tumor homing and growth [5], suggesting that targeting this protein in NSCLC may result in a strong therapeutic effect. Here, TMPRSS4 is linked to neoplasm.